Literature DB >> 21272194

Barriers to blood pressure control: a STITCH substudy.

Sigrid A E Nelson1, George K Dresser, Margaret K Vandervoort, Cindy J Wong, Brian G Feagan, Jeffrey L Mahon, Ross D Feldman.   

Abstract

Despite improvements in blood pressure (BP) control, a substantial percentage of patients do not achieve target. The relative importance of determinants of poor BP control is unclear. Therefore, the authors conducted a post hoc exploratory analysis to assess determinants of BP control. Data were collected in 45 general practices, which enrolled patients with uncontrolled hypertension. Antihypertensive medication changes throughout the 6-month follow-up period were documented. Baseline and 6-month BPs were recorded. Of the 2030 patients analyzed, 320 had diabetes. Overall, 42% of patients did not achieve BP control. In multivariate analysis, failure to intensify therapy was identified as a significant independent predictor of lesser BP reduction. Of patients unable to reach target after 6 months, only 25% were prescribed ≥ 3 drugs. Patients with diabetes were significantly less likely to reach target than those without (26% vs 64%, P<.001). Antihypertensive therapy prescribed to patients with diabetes was only marginally more intensive than to those without. In patients with hypertension, whether with or without coexisting diabetes, poor BP control appears to be at least partially due to failure to uptitrate antihypertensive therapy. Clinical inertia is likely an important barrier to BP control.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21272194      PMCID: PMC8673188          DOI: 10.1111/j.1751-7176.2010.00392.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  22 in total

Review 1.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

2.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

3.  Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.

Authors:  P Michael Ho; David J Magid; Susan M Shetterly; Kari L Olson; Pamela N Peterson; Frederick A Masoudi; John S Rumsfeld
Journal:  Arch Intern Med       Date:  2008-02-11

4.  Standards of medical care in diabetes--2009.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

5.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

Review 6.  A practical approach to achieving recommended blood pressure goals in diabetic patients.

Authors:  G L Bakris
Journal:  Arch Intern Med       Date:  2001 Dec 10-24

7.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

8.  A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial.

Authors:  Ross D Feldman; Guang Y Zou; Margaret K Vandervoort; Cindy J Wong; Sigrid A E Nelson; Brian G Feagan
Journal:  Hypertension       Date:  2009-02-23       Impact factor: 10.190

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  Barriers to optimal hypertension control.

Authors:  Gbenga Ogedegbe
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-08       Impact factor: 3.738

View more
  15 in total

1.  Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction.

Authors:  Phillip D Levy; Robina Josiah Willock; Michael Burla; Aaron Brody; James Mahn; Alexander Marinica; Samar A Nasser; John M Flack
Journal:  J Am Soc Hypertens       Date:  2016-10-28

2.  Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost-effectiveness Analysis.

Authors:  Michael J Twiner; Alexander L Marinica; Kenneth Kuper; Allen Goodman; James J Mahn; Michael J Burla; Aaron M Brody; Justin A Carroll; Robina Josiah Willock; John M Flack; Samar A Nasser; Phillip D Levy
Journal:  Acad Emerg Med       Date:  2017-01-30       Impact factor: 3.451

3.  Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service.

Authors:  A Amouzougan; A Deygat; B Trombert; E Constant; D Denarié; H Marotte; T Thomas
Journal:  Osteoporos Int       Date:  2015-06-24       Impact factor: 4.507

4.  Blood Pressure Lowering May Decrease Cognitive Decline; But Are We Ready to Lower Blood Pressure in the Real World?

Authors:  Madhuri Ramakrishnan; Gary Gronseth; Aditi Gupta
Journal:  J Clin Cardiol       Date:  2021

5.  Determinants of diabetes and hypertension control in ambulatory healthcare in Al ain, United arab emirates.

Authors:  Latifa M Baynouna; Nico Jd Nagelkerke; Thuraya A Al Ameri; Sanaa M Zein Al Deen; Habiba I Ali
Journal:  Oman Med J       Date:  2014-05

Review 6.  Exploring issues in difficult-to-treat hypertension.

Authors:  Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-10-30       Impact factor: 3.738

Review 7.  Factors associated with clinical inertia: an integrative review.

Authors:  Isabelle Aujoulat; Patricia Jacquemin; Ernst Rietzschel; André Scheen; Patrick Tréfois; Johan Wens; Elisabeth Darras; Michel P Hermans
Journal:  Adv Med Educ Pract       Date:  2014-05-08

Review 8.  Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review.

Authors:  Sanjay Kalra
Journal:  Cardiol Ther       Date:  2016-08-18

9.  Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy.

Authors:  Henry Punzi; Ali Shojaee; Jen-Fue Maa
Journal:  Ther Adv Cardiovasc Dis       Date:  2012-08-01

10.  Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial.

Authors:  Michel P Hermans; Moses Elisaf; Georges Michel; Erik Muls; Frank Nobels; Hans Vandenberghe; Carlos Brotons
Journal:  Diabetes Care       Date:  2013-07-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.